Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 118 of the 119 references it cites were found in a registry or an index; 8 of the 18 sources its claims cite were checked for support.

The global prevalence of autism spectrum disorder: A three-level meta-analysis

Open access

Abstract

Autism spectrum disorder (ASD) is one the most disabling developmental disorders, imposing an extremely high economic burden. Obtaining as accurate prevalence estimates as possible is crucial to guide governments in planning policies for identification and intervention for individuals with ASD and their relatives. The precision of prevalence estimates can be heightened by summative analyses of the data collected around the world. To that end, we conducted a three-level mixed-effects meta-analysis. A systematic search of the Web of Science, PubMed, EMBASE, and PsycINFO databases from 2000 up to 13 July 2020 was performed, and reference lists of previous reviews and existing databases of prevalence studies were screened. Overall, 79 studies were included in the analysis of ASD and 59-in the analysis of previously existing relevant diagnoses: 30 for Autistic Disorder (AD), 15 for Asperger Syndrome (AS), and 14 for Atypical Autism (AA) and Pervasive Developmental Disorder - Not Otherwise Specified (PDD-NOS); these research reports covered the period from 1994 to 2019. Pooled prevalence estimates were 0.72% (95% CI = 0.61-0.85) for ASD, 0.25% (95% CI = 0.18-0.33) for AD, 0.13% (95% CI = 0.07-0.20) for AS, and 0.18% (95% CI = 0.10-0.28) for the combined group of AA and PDD-NOS. Estimates were higher (1) for the studies that used records-review surveillance rather than other designs; (2) in North America compared with other geographical regions; and (3) in high-income compared with lower-income countries. The highest prevalence estimates were registered in the USA. There was an increase in autism prevalence estimates over time. The prevalence was also significantly higher for children aged between 6 and 12 years compared to children under the age of 5 and over the age of 13 years. Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42019131525, identifier CRD42019131525.

Overview

CoChat Summary

## TL;DR

This three-level meta-analysis estimated the global pooled prevalence of autism spectrum disorder (ASD) at 0.72% (95% CI 0.61–0.85) across studies from 1994–2019. Prevalence was higher in North America, in high-income countries, with records-review surveillance, and increased over time; the authors’ adjusted estimate for 2015–2019 in upper-middle/higher-income countries in Europe and North America was 1.18% (95% CI 0.92–1.48).

## Key findings

  • Across 79 studies and 220 ASD estimates, the pooled prevalence of ASD was 0.72% (95% CI 0.61–0.85), with total I² = 99.96%.
  • By diagnosis subgroup, pooled prevalence was 0.25% for Autistic Disorder (AD), 0.13% for Asperger Syndrome (AS), and 0.18% for the combined AA/PDD-NOS group.
  • Prevalence was higher in North America (1.01%) than in Europe (0.73%) and Asia (0.41%); by income group, it was highest in high-income countries (0.79%).
  • Prevalence increased over time from 0.25% (1994–1999) to 0.99% (2015–2019), and was highest among children aged 6–12 years (0.82%) versus under 5 years (0.60%) and over 13 years (0.57%).
  • By study design, the lowest prevalence estimates came from health insurance databases (0.35%) and administrative databases (0.48%), while records-review surveillance produced the highest estimates (1.22%).

## Methods

  • Systematic review and three-level mixed-effects meta-analysis registered in PROSPERO (CRD42019131525) and reported per PRISMA.
  • Searched Web of Science, PubMed, EMBASE, and PsycINFO; English-language studies published since 2000 were searched, with an update on 13 July 2020 and manual searching of databases/references.
  • Included geographically and temporally defined prevalence studies with formal ASD/diagnostic subgroup identification using DSM/ICD or gold-standard tools (e.g., ADOS, ADI), and sample sizes >1,000; quantitative synthesis used random-effects three-level models, moderator analyses, and meta-regression.

## Limitations

  • The authors state that only English-language studies were included, so some studies were missed.
  • They state that moderator/meta-regression analyses may be under-powered because of limited data and a minimum 5 data-point cutoff per covariate level.
  • They state that very substantial heterogeneity remained unaccounted for across all subgroups and models, which limits reliability and generalizability.
  • Evident from the text: the sample was heavily weighted toward high-income countries and the USA, which the authors note may confound income-related findings.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fpsyt.2023.1071181

Cites

118 of 118 references verified0 citation errors · 0 not checkable

Statistics

7 tests recomputed · 1 with the reported and recomputed p on opposite sides of .05

Figures

FIGURE 1 Search strategy. PRISMA flow diagram.
FIGURE 1 Search strategy. PRISMA flow diagram.CC BY · PubMed Central
FIGURE 2 The distribution of the total variance for ASD.
FIGURE 2 The distribution of the total variance for ASD.CC BY · PubMed Central
FIGURE 3 The meta-regression analysis of the effect of the HDI on the pooled prevalence of ASD.
FIGURE 3 The meta-regression analysis of the effect of the HDI on the pooled prevalence of ASD.CC BY · PubMed Central
FIGURE 4 The meta-regression analysis of the effect of the study time on the pooled prevalence of ASD.
FIGURE 4 The meta-regression analysis of the effect of the study time on the pooled prevalence of ASD.CC BY · PubMed Central
FIGURE 5 Influential observations by Cooks distance. 18—Hewitt et al. (43); 33—Zahorodny et al. (37); 42—Akhter et al. (44); 125—Kim et al. (47); 130—Aguilera et al. (38); 142—Baio et al. (45); 157—Maenner et al. (46); 202—Shaw et al. (48).
FIGURE 5 Influential observations by Cooks distance. 18—Hewitt et al. (43); 33—Zahorodny et al. (37); 42—Akhter et al. (44); 125—Kim et al. (47); 130—Aguilera et al. (38); 142—Baio et al. (45); 157—Maenner et al. (46); 202—Shaw et al. (48).CC BY · PubMed Central

Verification

Claims the paper makes

6 Valid · 0 Not valid · 6 Not checked · 73 Own results and interpretations

34 more claims

Create a free account to see all 85 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 15
  • It may state two separate claims as one. 38

Create a free account to see these claims.

Statistics that don’t add up

Each reported p-value recomputed from its test statistic and degrees of freedom.

1 of 1

Statistics recomputed

Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.

  • Doesn’t add upF(2, 217) = 0.35reported p < .05 · recomputed p = .705The two fall on opposite sides of .05

    “F(2, 217) = 0.35, p < .05”

  • ConsistentF(2, 211) = 8.58reported p < .001 · recomputed p < .001

    “F(2, 211) = 8.58, p < .001”

  • ConsistentF(9, 173) = 6.65reported p < .001 · recomputed p < .001

    “F(9, 173) = 6.65, p < .001”

  • ConsistentF(3, 214) = 199.6reported p < .001 · recomputed p < .001

    “F(3, 214) = 199.60, p < .001”

  • ConsistentF(1, 218) = 35.53reported p < .001 · recomputed p < .001

    “F(1, 218) = 35.53, p < .001”

5 of 7 · the rest aren’t loaded

2 more recomputed tests

Create a free account to see every test the Stats check recomputed.

See all tests — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

2 of 2

Citations

Cites

2 retracted

Show all 119 references

Research works printed but not linked: 6

  1. 2022, Autism Prevalence Studies Data. DataCDC.gov.
  2. 2022, Global Autism Prevalence Map.
  3. 2022, World Bank Country and Lending Groups – World Bank Data Help Desk.
  4. 2022, Human Development Index.
  5. Hill, 2016, Challenges and Options for Estimating the Prevalence of Autism in Population Surveys.
  6. 2022, Autism.

Cited by

See all 318

Metadata

Authors
Talantseva, O. I., Romanova, R. S., Shurdova, E. M., Dolgorukova, T. A., Sologub, P. S., Titova, O. S., Kleeva, D. F., & Grigorenko, E. L.
Affiliations
  • St Petersburg University (RU)
  • Sirius University of Science and Technology (RU)
  • National Research University Higher School of Economics (RU)
Corresponding author
Grigorenko, Elena L.
Venue
Frontiers in Psychiatry
Published
2023-02-09
Volume
14
Pages
1071181-1071181
ISSN
1664-0640 (ISSN-L)
OpenAlex
W4319768423
Cited by
318
References
119
Citations by year
2026: 104 · 2025: 127 · 2024: 70 · 2023: 16
FWCI
11.85
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Repository Saint Petersburg State University (Saint Petersburg State University) (submittedVersion)
  • Digital Commons-TMC (Texas Medical Center) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
  • Social Sciences › Psychology › Clinical Psychology › Family and Disability Support Research
Keywords
autism spectrum disorder, prevalence, autistic disorder, Asperger syndrome, pervasive developmental disorders, atypical autism, developmental disorders, global prevalence, prevalence trends, age differences in prevalence, income level differences, North America

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The global prevalence of autism spectrum disorder: A three-level meta-analysis. https://app.cochat.ai/papers/10.3389/fpsyt.2023.1071181
The paper
Talantseva, O. I., Romanova, R. S., Shurdova, E. M., Dolgorukova, T. A., Sologub, P. S., Titova, O. S., Kleeva, D. F., & Grigorenko, E. L. (2023). The global prevalence of autism spectrum disorder: A three-level meta-analysis. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2023.1071181

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.